Community

Scientist I – Pharmacology

Location – Cambridge, MA

Company Summary:

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize trans-formative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world.  If the answer is yes, then Editas Medicine is the place for you.

Primary Responsibilities:

The main responsibilities of the candidate are to assist with the strategy, planning and execution of activities related to pre-clinical pharmacology. Activities include:

• Strategy for and oversight of animal model development and characterization in the area of oncology and cell therapies
• Design experiments and develop assays critical to understand in-vivo therapeutic activity, efficacy, and PK/PD properties
• Suggest refinements and optimization to in-life procedures, based on study requests from project teams
• Perform pre-clinical proof-of-concept and interact with clinical development team to design and supervise IND-enabling studies
• Experience managing studies remotely through CRO collaborators
• Documentation of assay development and animal study results
• Responsible for write-up or review of pre-clinical pharmacology-related section of IND

Minimum Qualifications:

• PhD in pharmacology (or related disciplines) with a minimum of 3-5 years of industrial experience. Experience in oncology is a plus
• A broad knowledge and proven ability to develop/evaluate disease models for efficacy studies in oncology area
• Ability and commitment to high-quality research and the execution of research plans in a timely and organized manner
• Strong written and communication skills; and an ability to collaborate effectively with a diverse team in a fast-pace and dynamic environment

Personal Characteristics:

• Creative and strategic thinker with ability to adapt quickly to a high-growth, fast paced environment
• Able to communicate complex issues in a simple way, to orchestrate plans to resolve issues, and mitigate risks
• Willingness to roll-up sleeves and be hands-on
• Excellent interpersonal skills with the ability to develop important relationships with key internal and external stakeholders
• The ability to work cooperatively with others; the genuine desire to be a part of a team and contribute to organizational and team goals

We are an equal opportunity employer offering a competitive salary and benefits package. All applicants should be legally entitled to work for any employer in the US.

Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.

Director / Senior Director of IT Operations

Location – Cambridge, MA

Company Summary:

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize trans-formative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world.  If the answer is yes, then Editas Medicine is the place for you.

Primary Responsibilities:

• Day to day operations of Editas’s network, storage, security and telephony infrastructure
• Oversee the deployment, monitoring, maintenance, development, upgrade, and support of security systems, servers, desktop devices, IT Operations applications, networks and the service desk

• Responsibility for system configurations, Software installations, updates, & upgrades to Windows servers, applications, and other infrastructure systems.
• Monitoring system performance/availability & taking appropriate proactive steps to maximize uptime

• Manage and mature the IT service desk and ensure mutually defined SLA’s are managed and achieved
• Manage Editas’s IT infrastructure vendors, SaaS providers and hosting partners
• Develop capacity plans and budgets that meet the growth, scale and changing needs of the business
• Maintain a high level of infrastructure uptime in a fast-paced environment
• Develop and test disaster recovery and business continuity plans
• Develop, implement and maintain IT policies, procedures, and associated plans for security, data center, desktops and infrastructure based on industry-standard best practices, SOX and FDA requirements
• Develop and mature end user training on our growing portfolio of applications and tools

Minimum Qualifications:

• A minimum of 10 years of Information Technology experience, and 6 years of management experience

• Demonstrated ability to work on diverse projects simultaneously, requiring detailed analysis, creative/practical problem solving, time management, and sound judgment
• Ability to self-motivate while operating effectively in a team-oriented and collaborative environment
• Experience supporting a 100+ end user environment
• Experience in small company or start up environments (Life sciences preferred)
• Experience in vendor management, computer operations, network management, technical management and end user support
• Experience implementing and/or managing one or more of the following processes: IT incident/service request management, IT configuration management, computer system validation
• Experience with SaaS and hosted applications including Okta and Office 365
• Ability to work on a small, fast-paced IT team
• Strong communication and interpersonal skills
• Budget management experience
• Ability to manage multiple projects, activities and tasks simultaneously

Key Capabilities:

• Creative and strategic thinker with ability to adapt quickly to a high-growth, fast paced environment
• Able to communicate complex issues in a simple way, to orchestrate plans to resolve issues, and mitigate risks
• Willingness to roll-up sleeves and be hands-on
• Excellent interpersonal skills with the ability to develop important relationships with key internal and external stakeholders
• The ability to work cooperatively with others; the genuine desire to be a part of a team and contribute to organizational and team goals

Manager / Senior Manager Investor Relations

Location – Cambridge, MA

Company Summary:

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize trans-formative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world.  If the answer is yes, then Editas Medicine is the place for you.

Primary Responsibilities:

• Develop and execute the company’s investor relations strategy
• Develop written materials including press releases, conference call scripts, slide presentations, and Q&A documents; to prepare for quarterly calls, conference presentations, and other investor events
• Plan, manage, and oversee external events including conferences, analyst days, and non-deal roadshows
• Collaborate with leadership team and key stakeholders to define strategic communications delivered to investors and analysts
• Maintain comprehensive, current knowledge of Editas’ research and development approaches and business strategies to better inform IR strategy
• Develop and manage relationships and maintain regular communication with investors and analysts, to provide up-to-date information

Minimum Qualifications:

• Bachelor’s degree required; MBA or related graduate degree preferred
• Degree in life sciences a plus, but not required
• Experience in life sciences/biotechnology sector highly preferred
• Investment experience (sellside or buyside) or strategy/management consulting background highly desirable
• Strong written and verbal communication skills; outstanding presentation and interpersonal skills with the ability to translate complex financial and investment information
• High degree of proficiency in Microsoft Office, including PowerPoint for investor presentations and Excel for financial modeling
• Ability to adapt to dynamic and evolving priorities and respond to variable timelines with accuracy and urgency

Key Capabilities:

• Creative and strategic thinker with ability to adapt quickly to a high-growth, fast paced environment
• Able to communicate complex issues in a simple way, to orchestrate plans to resolve issues, and mitigate risks
• Willingness to roll-up sleeves and be hands-on
• Excellent interpersonal skills with the ability to develop important relationships with key internal and external stakeholders
• The ability to work cooperatively with others; the genuine desire to be a part of a team and contribute to organizational and team goals

Location: Boulder, CO

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

Editas Medicine in Boulder has an immediate opening for a Senior Director of Analytical Chemistry.  The Senior Director of Analytical Chemistry (SDAC) will lead the effort to build out capabilities to analyze RNA at increasing scale and under GLP and GMP control.  Working closely with the Editas quality system and Regulatory departments the SDAC will be responsible for establishing the analytical development effort on RNA and Ribonucleic acid protein complex for used in preclinical, toxicology, and clinical development.  The SDAC will report directly to the SVP and Boulder Site Head for the Editas Chemistry Department.  Working collaboratively with the Manufacturing and CMC groups of the company the SDAC will be responsible for defining performance metrics and deliverables that map onto the development goals of EM22.

Location: Cambridge, MA

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

We are looking for an enthusiastic, innovative and experienced scientist to join Biological Development group to support research activities across multiple programs for cell therapy. The potential candidate would be expected to lead the path from the discovery research through early clinical development to evaluate the pharmacology of novel therapeutic approaches. Collaborative interactions with therapeutic area research, preclinical safety, biomarker (imaging or biochemical) and clinical development teams are critical to success in the role.

Location: Cambridge, MA

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

We are currently building an informatics platform that spans a wide range of our needs ranging from LIMS development, lab automation, and data pipeline design and management.  To support our platform, Editas is seeking to hire an informatics developer with proven expertise in designing and implementing a LIMS to handle a variety of lab functions and experiments (NGS, etc.).  They should also have knowledge and experience managing scientific data and processes, building automation, and interacting with scientists and researchers.  Experience with modern development practices, Tableau, Java and web services development and cloud computing is highly desirable as well.

Professional experience developing Java software in biotech required.  You should be familiar with terms like JAXB, JSON, GIT, Jersey, AWS, Swagger, web services, serverless and HTML5.

Location: Boulder, CO

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

We are currently building an informatics platform that spans a wide range of our needs ranging from LIMS development, lab automation, and data pipeline management.  To support our platform, Editas is seeking to hire an informatics developer with proven expertise in designing and implementing a LIMS to handle a variety of lab functions and experiments (NGS, etc.).  They should also have knowledge and experience managing scientific data and processes, building automation, and interacting with scientists and researchers.  Experience with modern development practices, Tableau, web and web services development and cloud computing is highly desirable as well.

Position will be working remotely to a small informatics team that designs, develops, and deploys the enterprise software systems that support our scientific team. Professional experience developing Java software in biotech required.  You should be familiar with terms like JAXB, JSON, GIT, Jersey, AWS, web services, serverless and HTML5.

Location: Boulder, CO

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

The Director of Process Chemistry (DPC) will lead the effort to build out capabilities to synthesize RNA at increasing scale and under GLP and GMP control.

Editas Medicine is a transformative genome editing company with a mission to translate its gene editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Editas Manufacturing team provides a unique opportunity to contribute to the clinical translation of CRISPR technology by managing efforts that support the development and operationalization of Editas’ clinical programs.

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Editas is looking for a versatile and highly-motivated individual to contribute to business development activities of a rapidly growing biotech.  Reporting to Vice President of Business Development the Senior Director of Business Development will play a key role in defining and driving Editas’ strategic initiatives, and will be responsible for the identification, evaluation and execution of strategic collaborations.

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

We have an immediate need for a Sr. Research Associate, Biophysical Analytical Development to join our team.

Location: Cambridge, MA

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

We are seeking an experienced lab head who will lead a team applying high throughput technologies to identify, characterize and select CRISPR/CAS9 and Cpf1 (Cas12a) therapeutic candidates.  The screening team works collaboratively across several therapeutic pipeline projects to develop and run cell assay models.  These models include standard human and mouse cell lines, primary human T-cells, as well as hematopoietic and pluripotent stem cells; and, will utilize various end points readouts including NGS, FACS, RT-qPCR, and other protein and pathway-based detection platforms.  The team lead will have a strong intellectual presence within projects, defining key project needs, analyzing and managing large screening data sets, and presenting results and recommendations.

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

This role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies.

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world.  If the answer is yes, then Editas Medicine is the place for you.

The Associate Director, Financial Planning & Analysis (“FP&A”) is a key member of the Editas Finance team. This role will lead all FP&A projects and initiatives at Editas and will work closely with the accounting group to perform other finance-related responsibilities. This role will work directly with executive management and there is an opportunity to interact with the Board of Directors through the Audit Committee, if desired.

Associate Director, Business Development

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

Editas is looking for a versatile and highly-motivated individual to support the business development activities of a rapidly growing biotech start-up.  Reporting to Vice President of Business Development the Associate Director or Director of Business Development will play a key role in driving Editas’ strategic initiatives, and will be responsible for the identification, evaluation and execution of strategic collaborations.  Activities will include business case development, due diligence, strategic and valuation analyses, transactional activities, and executing deals.   The successful candidate will be capable of externally representing Editas on each of these facets, and effectively working cross-functionally to analyze, review and gain internal support for business development initiatives.

Location: Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.
Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world? If the answer is yes, then Editas Medicine is the place for you.

The immunogenetics team is seeking an experienced and highly motivated molecular biologist/immunologist with expertise in genetic engineering of hematopoietic cells.   We are seeking a thoughtful, organized, and creative scientist who will play a key role in the generation and characterization of novel cell therapy products for cancer.

Location: Cambridge, MA

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

Editas is seeking a Vice President of Discovery Biology to lead a group of biologists developing CRISPR/Cas9-based therapies for our current ocular disease platform and other new indications diseases for which in vivo gene editing may provide a potentially differentiated therapy.

Location: Cambridge, MA

What if you could repair broken genes?  That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world?  If the answer is yes, then Editas Medicine is the place for you.

The immunogenetics team is seeking a highly motivated immunologist/molecular biologist with expertise in genetic engineering of hematopoietic cells to join our rapidly growing team.  The successful candidate will help build a new class of immuno-oncology products and will test novel engineered effector cell modalities using in vitro and in vivo human tumor models.  Experience with mammalian cell culture, including isolating and propagating human effector cells, a plus.  This is an excellent opportunity to be at the cutting edge of engineered cell medicines by combining the power of immune-oncology and CRISPR-based gene editing.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Job Description

The immunogenetics team is seeking an experienced and highly motivated cell and molecular biologist with expertise in induced pluripotent stem cells (iPSC), genetic engineering and hematopoietic cell differentiation. The successful candidate will join a multidisciplinary team dedicated to building an iPSC platform for the development of novel engineered cell products. The individual will be responsible for generating genetically engineered iPSC lines to support internal programs and external collaborations and must have in depth knowledge of iPSC derivation, characterization and differentiation. The position will require independent research, mentoring skills, and the ability to work with team members across our organization. This is an excellent opportunity to be at the cutting edge of engineered cell medicines by combining the potential of the iPSC platform and CRISPR-based gene editing.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Editas is seeking a highly motivated Research Associate I/II to join our Biological Development group. The candidate will contribute as part of a dynamic team to the development of gene-editing based ex vivo cell therapies in multiple disease areas, including hematology and immune-oncology. In this role, the candidate will be responsible for performing studies to support the efficacy and safety evaluation of gene editing lead molecules. The successful candidate is expected to have proven practical experience in aseptic cell culture. The candidate will be frequently interacting with the discovery, platform and process development groups. Strong communication skills, and the ability to work in a fast-paced and team-oriented environment will also be vital.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

The Biological Development department at Editas is seeking a motivated and experienced scientist to lead the biomarker and bioanalytical group for development of analytical assays to support the preclinical and clinical programs in the ocular, hematology and oncology therapeutic areas. The qualified candidate will be responsible to design analytical strategy and develop the appropriate analytical methods to fit for purpose in IND-enabling studies and for regulatory submission. The responsibility will also include the assay transfer and the management of CRO’s. This individual is expected to be a great team player, enthusiastic and enjoy working in an innovative, collaborative and fast-pace environment.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

The Biological Development department at Editas is seeking a motivated scientist to join the biomarker and bioanalytical group for development of analytical assays to support the preclinical and clinical programs in the ocular, hematology and oncology therapeutic areas. The qualified candidate will be responsible to develop the analytical assays for PK/PD, biodistribution, and immunogenicity as well as biomarker discovery and qualification. The responsibility will include assay development, sample testing and technical report generation to support preclinical studies and regulatory submission. This individual is expected to be a great team player, enthusiastic and enjoy working in an innovative, collaborative and fast-pace environment.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Editas is seeking a Scientist/Senior Scientist with a focus on research and development of CRISPR-based in vivo therapies. The candidate will be part of the in vivo discovery group that is responsible for discovering potential therapies for ophthalmology and rare diseases. The successful candidate will interact effectively with the research and platform groups, as well as external collaborators. The individual will provide scientific expertise and guidance for target selection, early research to candidate selection, and transition to early clinical development.

A successful candidate will demonstrate extensive knowledge in molecular and cellular pathways in ophthalmology and rare diseases. Experience with in vivo models is essential. Working experience with gene editing, cellular models, and cell manufacture are desirable but not essential.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Editas is seeking a Research Associate/Senior Research Associate with a focus on cell biology, stem cells and related assays. The candidate will be part of the cell biology group that is responsible for discovering potential therapies for ophthalmology and other diseases. The successful candidate will interact effectively with the research and platform groups. The individual will provide support to cell biology, stem cells, differentiation, disease modeling, gene editing and cell-based assays.

A successful candidate will demonstrate extensive knowledge in molecular and cell biology and stem cells. Work experience with gene editing is highly desirable.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Editas is seeking a highly motivated Research Associate I/II to join our in vivo pharmacology group. The candidate will be responsible for conducting preclinical animal studies to support the development of gene-editing based therapies in multiple disease areas, including ophthalmology, oncology, and hematology. The successful candidate will be part of a dynamic team and will interact with the discovery, platform, process development groups, as well as contract research organizations. The successful candidate should demonstrate strong work ethics and ability to work in a fast-paced and highly demanding work environment.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

The Immunogenetics team is looking to add highly talented and motivated candidates to assist in the development of novel immune-oncology therapies for cancer.  The successful candidate will contribute to exploring innovative cell-based anti-tumor strategies for cancer using gene editing and genetic engineering as part of a dynamic, multidisciplinary discovery team dedicated to the development of novel first in class therapeutics. This position will serve a critical function in providing high-level laboratory support to project leads with a focus on cellular and molecular immunology. We are seeking a highly motivated and innovative senior research associate with immunology/cancer biology expertise.

Location – Cambridge, MA

What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases.

We’re looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before.

Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world. If the answer is yes, then Editas Medicine is the place for you.

Editas Medicine is seeking a highly motivated Research Associate I/II to join our ex vivo Immunogenetics group. In this role, you will contribute to the pre-clinical development of gene-edited cell products for oncology indications. An ideal candidate should have a background in immunology, cancer biology, and a strong interest in genome editing. The successful candidate will be part of a dynamic team and will interact with the discovery, platform, process development groups, as well as contract research organizations. The successful candidate should demonstrate strong work ethics and ability to work in a fast-paced and highly demanding work environment.

Location – Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas’ efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to perform experiments that generate data to guide development of cellular analytical assays and standard operating procedures (SOPs) for the preparation of cellular therapy clinical studies. Candidate must be experienced with aseptic technique and be versatile to assist in the development of qualified assays for autologous or normal donor cellular products derived from different lineages of cells (T cells, HSCs, etc.).

Location – Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.  Editas is seeking a Scientist/Senior Scientist with a focus on research and development of CRISPR/Cas9-based ocular medicines.

The candidate will be part of the ophthalmology discovery group that is responsible for discovering medicines for  both inherited retinal degenerations and genetically treatable ocular diseases. The successful candidate will interact effectively with the pre-clinical and platform groups, as well as external collaborators.  The individual will provide scientific expertise and guidance for target selection, early research candidate selection, and transition into early clinical development.

A successful candidate will demonstrate extensive knowledge in molecular and cellular pathways in ophthalmology.  Experience with cellular and animal models is essential as well as experience with gene editing and molecular skills.